India, Jan. 21 -- CORONA Remedies Limited has achieved a key milestone in its global expansion journey with the successful accreditation of the EAEU–GMP (Eurasian Economic Union – Good Manufacturing Practices) certification.
The certification enables CORONA Remedies to enter five EAEU member countries—Russia, Kyrgyzstan, Armenia, Belarus, and Kazakhstan—under a B2B business model, providing access to a pharmaceutical market estimated at USD 25 billion. The development aligns with the company's long-term strategy of building sustainable international partnerships.
EAEU–GMP accreditation further strengthens CORONA's presence across its four core therapeutic areas—Women's Health, Cardio-Diabetes, Pain Mana...